InvestSMART

ResMed Inc. (ASX: RMD) - Announcements

Current share price for RMD : $30.500 1.18 (4.02%)+

ASX company news and announcements for ResMed Inc. (RMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ResMed Inc. (RMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ResMed Inc. (RMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ResMed Inc. (RMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$44,048 4 Statement of changes in beneficial ownership of securities 9 Oct 2025 8:29AM $43.010 $30.500 fallen by 29.09%
$44,048 144 Report of proposed sale of securities 9 Oct 2025 8:23AM $43.010 $30.500 fallen by 29.09%
$44,048 Statement of CDIs on issue - RMD 3 Oct 2025 12:16PM $42.120 $30.500 fallen by 27.59%
$44,048 Notice of Annual General Meeting Additional Materials 3 Oct 2025 8:27AM $40.840 $30.500 fallen by 25.32%
$44,048 Notice of Annual General Meeting/Proxy Form 3 Oct 2025 8:27AM $40.840 $30.500 fallen by 25.32%
$44,048 144 Report of proposed sale of securities 2 Oct 2025 8:25AM $41.360 $30.500 fallen by 26.26%
$44,048 144 Report of proposed sale of securities 2 Oct 2025 8:25AM $41.360 $30.500 fallen by 26.26%
$44,048 144 Report of proposed sale of securities 9 Sep 2025 8:24AM $41.920 $30.500 fallen by 27.24%
$44,048 Statement of CDIs on issue - RMD 4 Sep 2025 10:16AM $41.315 $30.500 fallen by 26.18%
$44,048 Initial statement of beneficial ownership of securities 3 Sep 2025 8:21AM $41.880 $30.500 fallen by 27.17%
$44,048 PROPOSED SALE OF SECURITIES 3 Sep 2025 8:21AM $41.880 $30.500 fallen by 27.17%
$44,048 Statement of changes in beneficial ownership 27 Aug 2025 8:12AM $44.050 $30.500 fallen by 30.76%
$44,048 Statement of changes in beneficial ownership 27 Aug 2025 8:12AM $44.050 $30.500 fallen by 30.76%
$44,048 Statement of changes in beneficial ownership 27 Aug 2025 8:12AM $44.050 $30.500 fallen by 30.76%
$44,048 Statement of changes in beneficial ownership 27 Aug 2025 8:12AM $44.050 $30.500 fallen by 30.76%
$44,048 Statement of changes in beneficial ownership 27 Aug 2025 8:11AM $44.050 $30.500 fallen by 30.76%
$44,048 144 Report of proposed sale of securities 19 Aug 2025 3:06PM $44.100 $30.500 fallen by 30.84%
$44,048 Departure of Directors and Election of Directors 19 Aug 2025 8:14AM $43.800 $30.500 fallen by 30.37%
$44,048 Update - Dividend/Distribution - RMD 18 Aug 2025 8:23AM $44.000 $30.500 fallen by 30.68%
$44,048 Statement of changes in beneficial ownership of securities 12 Aug 2025 8:19AM $43.510 $30.500 fallen by 29.90%
$44,048 Resmed Form 10-K Annual Report 11 Aug 2025 8:21AM $43.020 $30.500 fallen by 29.10%
$44,048 Resmed Form 10-K Annual Report 11 Aug 2025 8:21AM $43.020 $30.500 fallen by 29.10%
$44,048 144 Report of proposed sale of securities 8 Aug 2025 8:24AM $43.020 $30.500 fallen by 29.10%
$44,048 Statement of changes in beneficial ownership of securities 8 Aug 2025 8:24AM $43.020 $30.500 fallen by 29.10%
$44,048 Statement of changes in beneficial ownership of securities 8 Aug 2025 8:24AM $43.020 $30.500 fallen by 29.10%

101 - 125 of 701 results

Page 5 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.